San-Pen Pharmaceuticals Private Limited
About San-Pen Pharmaceuticals Private Limited
Data last updated:
San-Pen Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 04 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21009MH2023PTC402283. Its GSTIN is 37ABKCS7454C1Z3 (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Maheswara Rao Edubilli (Managing Director) and Bhaskararao Vakada.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.76 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.33 Lakh (net margin 4.6%) and EBITDA of ₹8.37 Lakh (EBITDA margin 11.5%).
As per MCA filings, the company has open charges of ₹55.1 Lakh and satisfied charges of ₹10 Lakh on record.
Company details
Contact details
San-Pen Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressPlot No – 710G, K Raheja Platinum Andheri, Mumbai, Maharashtra, India – 400059
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of San-Pen Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of San-Pen Pharmaceuticals Private Limited, buy the company report.
Financials of San-Pen Pharmaceuticals Private Limited
FY 2025 filings availableSan-Pen Pharmaceuticals Private Limited reported revenue of ₹72.76 Lakh (up 189% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 189% in the latest year. EBITDA rose 246% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹8.37 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3.33 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 11.5% | |
| Net Profit Margin | 4.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of San-Pen Pharmaceuticals Private Limited, buy the company report.
Board of directors of San-Pen Pharmaceuticals Private Limited
San-Pen Pharmaceuticals has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaskararao Vakada | Director | 01 Aug 2024 | 2 Years 3 Months | Current |
| Ravindra Korada | Director | 01 Aug 2024 | 2 Years 3 Months | Current |
| Maheswara Rao Edubilli | Managing Director | 04 May 2023 | 3 Years 5 Months | Current |
| Yenda Charan Babu | Director | 04 May 2023 | 3 Years 5 Months | Current |
| Nagamani Edubilli | Director | 22 May 2026 | 0 Years 5 Months | Current |
| Lakshmi Gandeti | Director | 22 May 2026 | 0 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jan 2026 | 101225286 | Idbi Bank Limited | ₹30 Lakh | Open | |
| 27 Oct 2025 | 101216246 | Hdfc Bank Limited | ₹12.5 Lakh | Open | |
| 27 Oct 2025 | 101216247 | Hdfc Bank Limited | ₹12.6 Lakh | Open | |
| 10 Jan 2025 | 101067370 | Idbi Bank Limited | ₹10 Lakh | Satisfied |
To see the full charge records of San-Pen Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving San-Pen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for San-Pen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
San-Pen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37ABKCS7454C1Z3 | Andhra Pradesh | Active | 15 Jun 2023 |
To see the full GST registrations and return filing status of San-Pen Pharmaceuticals Private Limited, buy the company report.
Recent activity
San-Pen Pharmaceuticals Private Limited has 6 board changes on record since 2023: 6 appointments. The latest: Lakshmi Gandeti was appointed as Director on 22 May 2026.
2 earlier events are in the company report.
Frequently asked questions
San-Pen Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 04 May 2023 (3+ years old) and is registered under CIN U21009MH2023PTC402283.
San-Pen Pharmaceuticals has 6 current directors:
- Maheswara Rao Edubilli - Managing Director
- Bhaskararao Vakada - Director
- Ravindra Korada - Director
- Yenda Charan Babu - Director
- Nagamani Edubilli - Director
- Lakshmi Gandeti - Director
The latest financial statements of San-Pen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of San-Pen Pharmaceuticals is 37ABKCS7454C1Z3, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of San-Pen Pharmaceuticals is U21009MH2023PTC402283. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
San-Pen Pharmaceuticals was incorporated on 04 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Lakshmi Gandeti was appointed as Director on 22 May 2026. Nagamani Edubilli was appointed as Director on 22 May 2026. Bhaskararao Vakada was appointed as Director on 01 Aug 2024. San-Pen Pharmaceuticals has 6 board changes on record in total.
The registered office of San-Pen Pharmaceuticals is at Plot No – 710G, K Raheja Platinum Andheri, Mumbai, Maharashtra, India – 400059.
San-Pen Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
San-Pen Pharmaceuticals has open charges of ₹55.1 Lakh and satisfied charges of ₹10 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
